Abstract | PURPOSE: In 2010, we reported that selenium (Se) supplementation during radiation therapy (RT) is effective for increasing blood Se levels in Se-deficient cervical and uterine cancer patients, and reduced the number of episodes and severity of RT-induced diarrhea. In the current study, we examine whether of Se supplementation during adjuvant RT affects long-term survival of these patients. PATIENTS AND METHODS: Former patients were identified and questioned with respect to their health and well-being. RESULTS: A total of 81 patients were randomized in the initial supplementation study, 39 of whom received Se ( selenium group, SeG) and 42 of whom served as controls (control group, CG). When former patients were reidentified after a median follow-up of 70 months (range = 0-136), the actuarial 10-year disease-free survival rate in the SeG was 80.1% compared to 83.2% in the CG (P = .65), and the actuarial 10-year overall survival rate of patients in the SeG was 55.3% compared to 42.7% in the CG (P = .09). CONCLUSIONS: Our extended follow-up analysis demonstrates that Se supplementation had no influence on the effectiveness of the anticancer irradiation therapy and did not negatively affect patients' long-term survival. In view of its positive effects on RT-induced diarrhea, we consider Se supplementation to be a meaningful and beneficial adjuvant treatment in Se-deficient cervical and uterine cancer patients while undergoing pelvic radiation therapy.
|
Authors | Ralph Muecke, Oliver Micke, Lutz Schomburg, Michael Glatzel, Berthold Reichl, Klaus Kisters, Ulrich Schaefer, Jutta Huebner, Hans T Eich, K Fakhrian, Irenaeus A Adamietz, Jens Buentzel, German Working Group Trace Elements and Electrolytes in Oncology-AKTE |
Journal | Integrative cancer therapies
(Integr Cancer Ther)
Vol. 13
Issue 6
Pg. 463-7
(Nov 2014)
ISSN: 1552-695X [Electronic] United States |
PMID | 25015649
(Publication Type: Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2014. |
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Diarrhea
(etiology, prevention & control)
- Dietary Supplements
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Radiation Injuries
(prevention & control)
- Radiotherapy, Adjuvant
(adverse effects, methods)
- Selenium
(blood, deficiency)
- Sodium Selenite
(therapeutic use)
- Survival Rate
- Time Factors
- Uterine Cervical Neoplasms
(pathology, radiotherapy)
- Uterine Neoplasms
(pathology, radiotherapy)
|